Bionews announces poster win in trial methodology category at 2023 CNS Summit
Winning poster presentation highlights company’s accelerated ability to connect patient communities with clinical trials.
Bionews empowers Friedreich’s Ataxia community with inaugural live webinar
Panel of experts and patients provided tips on management, treatment, and financial planning for Friedreich’s Ataxia patients and caregivers.
Bionews Unveils New Brand Identity for Websites Highlighting Patient-centric Mission
Bionews Inc. unveiled new branding across each of its 68 owned and operated media websites in the rare and chronic disease space. This effort includes a logo suite and visual identity for each website and establishment of Bionews as the global parent company.
Bionews Staff Writer Hawken Miller 1 of 25 Selected for Prestigious Rare Disease Journalism Fellowship From National Press Foundation
Bionews announced today that Hawken Miller, a staff writer and columnist on its website Muscular Dystrophy News Today, is the recipient of a Rare Disease Journalism Fellowship by the National Press Foundation (NPF).
Bionews Named Finalist by Medical Marketing & Media (MM&M) for ‘2021 Best Healthcare Consumer Media Brand’
Bionews announced it has been named a finalist in the 2021 Medical Marketing & Media Awards (MM&M) in the category of Best Healthcare Consumer Media Brand with its entry entitled “Bionews Adopts Insider Approach to Content Development to Help People with Rare.”